August 20, 2019

Gelest Joins AMR Challenge

Gelest, Inc. joined The Antimicrobial Resistance (AMR) Challenge launched by the U.S. Government and CDC in September 2018. The AMR Challenge is an effort to accelerate the fight against antimicrobial resistance through committed action across governments and industries. Gelest manufactures BIOSAFEĀ® Antimicrobials that inhibit microorganism growth by physically puncturing the cell microbe membrane, killing the microbes on contact by electrocuting them.

READ THE PRESS RELEASE

Still Have Questions?

Contact Us